Leukocyte immunoglobulin(Ig)-like receptors(LILRs),also known as CD85 and immunoglobulin-like transcripts(ILTs),play pivotal roles in regulating immune responses.These receptors define an immune checkpoint that immune...Leukocyte immunoglobulin(Ig)-like receptors(LILRs),also known as CD85 and immunoglobulin-like transcripts(ILTs),play pivotal roles in regulating immune responses.These receptors define an immune checkpoint that immune therapy can target.Through cis or trans interactions with human leukocyte antigen(HLA)-G,the two most abundantly expressed inhibitory LILRs,LILRB1,and LILRB2(LILRB1/2,also known as CD85j/d and ILT2/4),are involved in immunotolerance in pregnancy and transplantation,autoimmune diseases,and immune evasion by tumors.Although the discrete domains of LILRB1/2 are clear,the assembly mode of the four extracellular Ig-like domains(D1,D2,D3,and D4)remains unknown.Previous data indicate that D1D2 is responsible for binding to HLA class I(HLA-I),but the roles of D3D4 are still unclear.Here,we determined the crystal structure of the four Ig-like domain LILRB2 and four-domain LILRB1 in complex with HLA-G1.The angles between adjacent domains and the staggered assembly of the four domains suggest limited flexibility and limited plasticity of the receptors during ligand binding.The complex structure of four domain LILRB1 and HLA-G1 supports the model that D1D2 is responsible for HLA-I binding,while D3D4 acts as a scaffold.Accordingly,cis and trans binding models for HLA-I binding to LILRB1/2 are proposed.The geometries of LILRB1/2 in complex with dimeric and monomeric HLA-G1 suggest the accessibility of the dimeric receptor,which in turn,transduces more inhibitory signals.The assembly of LILRB1/2 and its binding to HLA-G1 could aid in the design of immune regulators and benefit immune interference.展开更多
基金supported by the Strategic Priority Research Program of CAS(grant no.XDA12020358)the National Basic Research Program(973)of China(grant no.2015CB910503)+2 种基金the National Natural Science Foundation of China(NSFC,grant nos 31502078 and 31390432)supported by the Youth Innovation Promotion Association CAS(grant no.2018119)supported by the Young Elite Scientist Sponsorship Program by CAST(2016QNRC001)。
文摘Leukocyte immunoglobulin(Ig)-like receptors(LILRs),also known as CD85 and immunoglobulin-like transcripts(ILTs),play pivotal roles in regulating immune responses.These receptors define an immune checkpoint that immune therapy can target.Through cis or trans interactions with human leukocyte antigen(HLA)-G,the two most abundantly expressed inhibitory LILRs,LILRB1,and LILRB2(LILRB1/2,also known as CD85j/d and ILT2/4),are involved in immunotolerance in pregnancy and transplantation,autoimmune diseases,and immune evasion by tumors.Although the discrete domains of LILRB1/2 are clear,the assembly mode of the four extracellular Ig-like domains(D1,D2,D3,and D4)remains unknown.Previous data indicate that D1D2 is responsible for binding to HLA class I(HLA-I),but the roles of D3D4 are still unclear.Here,we determined the crystal structure of the four Ig-like domain LILRB2 and four-domain LILRB1 in complex with HLA-G1.The angles between adjacent domains and the staggered assembly of the four domains suggest limited flexibility and limited plasticity of the receptors during ligand binding.The complex structure of four domain LILRB1 and HLA-G1 supports the model that D1D2 is responsible for HLA-I binding,while D3D4 acts as a scaffold.Accordingly,cis and trans binding models for HLA-I binding to LILRB1/2 are proposed.The geometries of LILRB1/2 in complex with dimeric and monomeric HLA-G1 suggest the accessibility of the dimeric receptor,which in turn,transduces more inhibitory signals.The assembly of LILRB1/2 and its binding to HLA-G1 could aid in the design of immune regulators and benefit immune interference.
